Globalinvestmentalert.com Profiles Today’s Market Movers : . (OTCQB: WNYN) Warp 9, Inc. (OTCQB: AMBS) Amarantus Biosciences, Inc.
Globalinvestmentalert.com Special Gainers Alert: (OTCQB: WNYN), (OTCQB: AMBS)
TAMPA, Fla., Nov 2nd, 2012 -- Global Investment Alert your online resource for microcap stock news and information, GlobalInvestmentAlert.com offers a free newsletter featuring some of the hottest penny stock picks available. Globalinvestmentalert.com finds the best penny stock picks in today’s market. We keep you informed on fast moving, big gainer penny stocks. Our last three alerts have gained 1800%. To receive our amazing penny stock newsletter and alerts go to http://www.globalinvestmentalert.com
*** Today’s Market Movers***
(OTCQB: WNYN) Warp 9, Inc. Another strong open for WNYN this morning. Up 150% and trading steady. Add that to the 500% gain yesterday and WNYN is a prime mover!
(OTCQB: WNYN) Warp 9, Inc. is the premier provider of e-commerce services for midsize online sellers. Our Total Commerce Platform (TCP) is a cloud based, state-of-the-art e-commerce platform that provides online sellers with the highest level of functionality, performance and ease of use in the industry. Offered on a fully managed software-as-a-service model, Total Commerce Platform allows customers to focus on their core online businesses, rather than on technical implementations. We also offer industry leading mobile commerce solutions.
Warp 9 offers highly customized services at reasonable prices and we are always available to our online sellers, 24 hours a day, 7 days a week, 365 days a year. When you need us, we are there. When you grow, so does your scalable e-commerce platform. Your business is our business!
Get a free report on WNYN http://www.globalinvestmentalert.com/land/analysisreport.html
(OTCQB: AMBS) Amarantus BioSciences, Inc. is on fire this morning gaining another 46% over the triple digit gains yesterday. Could be one of this week’s big gainers .
(OTCQB: AMBS) Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company focuses on developing its intellectual property and proprietary technology to develop drug candidates to treat human disease. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”).
MANF is a protein that corrects protein misfolding. Protein misfolding is one of the major causes of apoptosis (cell death). This property provides a compelling rationale for the research & development of MANF-based products as therapeutics for human disease. Amarantus’ lead MANF product development effort is centered on a therapy for Parkinson ’s disease.
The Company also owns an inventory of 88 cell lines that the Company refers to as PhenoGuard Cell Lines. MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. The Company believes that it may identify additional therapeutic proteins from its inventory of PhenoGuard Cell Lines.
Get a free report on AMBS - http://www.globalinvestmentalert.com/land/analysisreport.html
Globalinvestmentalert.com offers a free newsletter featuring some of the best penny stock picks available. Our sole purpose is to find the best penny stock picks - period. To receive our awesome penny stock newsletter and alerts go to http://Globalinvestmentalert.com
Timing is everything when trading Penny Stocks. Be The First to Know by joining the GlobalInvestmentAlert.com newsletter. Our last four alerts have given our members over 1500% in gains.
For the Best Damn Stock Picks Subscribe to http://www.Globalinvestmentalert.com/
Disclosure: GlobalInvestmentAlert.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GlobalInvestmentAlert.com website, for complete risks and disclosures
Subscribe Here - http://www.Globalinvestmentalert.com/
Disclosure: Globalinvestmentalert.com/ is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Global Investment Alert Inc has not been compensated for this report.
Please visit http://Globalinvestmentalert.com/ for complete risks and disclosures.
CONTACT: Globalinvestmentalert.com / mailto:firstname.lastname@example.org
SOURCE Global Investment Alert, Inc.